# Donnelley Financial Solutions, Inc.: overview

DFIN · NYSE · CIK 1669811 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dfin.md) · [Financials](/companies/dfin/financials.md) · [Filings](/companies/dfin/filings.md) · [Insiders](/companies/dfin/insiders.md)

Latest reported revenue: [$224.2m](/filings/0001193125-26-326099.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-326099).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [180](/filings/0001193125-25-256296.md) | [156 d](/filings/0001193125-26-054586.md) | [201](/filings/0001193125-26-206350.md) | [218](/filings/0001193125-26-326099.md) | [175](/filings/0001193125-25-256296.md) | [173 d](/filings/0001193125-26-054586.md) | [206](/filings/0001193125-26-206350.md) | [224](/filings/0001193125-26-326099.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [10.1%](/filings/0001193125-25-256296.md) | [6.0% d](/filings/0001193125-26-054586.md) | [22.8%](/filings/0001193125-26-206350.md) | [24.2%](/filings/0001193125-26-326099.md) | [16.1%](/filings/0001193125-25-256296.md) | [8.3% d](/filings/0001193125-26-054586.md) | [23.6%](/filings/0001193125-26-206350.md) | [25.0%](/filings/0001193125-26-326099.md) |
| Net margin | % | [4.8%](/filings/0001193125-25-256296.md) | [4.0% d](/filings/0001193125-26-054586.md) | [15.4%](/filings/0001193125-26-206350.md) | [16.6%](/filings/0001193125-26-326099.md) | [(23.3%)](/filings/0001193125-25-256296.md) | [3.6% d](/filings/0001193125-26-054586.md) | [16.3%](/filings/0001193125-26-206350.md) | [16.2%](/filings/0001193125-26-326099.md) |
| Diluted EPS | $ per share | [0.29](/filings/0001193125-25-256296.md) | not reported | [1.05](/filings/0001193125-26-206350.md) | [1.28](/filings/0001193125-26-326099.md) | [(1.49)](/filings/0001193125-25-256296.md) | not reported | [1.27](/filings/0001193125-26-206350.md) | [1.44](/filings/0001193125-26-326099.md) |
| Free cash flow | $m | [67.3 d](/filings/0001193125-25-256296.md) | [41.3 d](/filings/0001193125-26-054586.md) | [(51.0)](/filings/0001193125-26-206350.md) | [51.7 d](/filings/0001193125-26-326099.md) | [59.2 d](/filings/0001193125-25-256296.md) | [47.9 d](/filings/0001193125-26-054586.md) | [(16.0)](/filings/0001193125-26-206350.md) | [61.2 d](/filings/0001193125-26-326099.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [993](/filings/0000950170-24-017094.md) | [834](/filings/0000950170-25-022207.md) | [797](/filings/0001193125-26-054586.md) | [782](/filings/0001193125-26-054586.md) | [767](/filings/0001193125-26-054586.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [22.1%](/filings/0000950170-24-017094.md) | [17.4%](/filings/0000950170-25-022207.md) | [13.8%](/filings/0001193125-26-054586.md) | [17.5%](/filings/0001193125-26-054586.md) | [18.4%](/filings/0001193125-26-054586.md) |
| Net margin | % | [14.7%](/filings/0000950170-24-017094.md) | [12.3%](/filings/0000950170-25-022207.md) | [10.3%](/filings/0001193125-26-054586.md) | [11.8%](/filings/0001193125-26-054586.md) | [4.2%](/filings/0001193125-26-054586.md) |
| Diluted EPS | $ per share | [4.14](/filings/0000950170-24-017094.md) | [3.17](/filings/0000950170-25-022207.md) | [2.69](/filings/0001193125-26-054586.md) | [3.06](/filings/0001193125-26-054586.md) | [1.15](/filings/0001193125-26-054586.md) |
| Free cash flow | $m | [138](/filings/0000950170-24-017094.md) | [96.0](/filings/0000950170-25-022207.md) | [62.2](/filings/0001193125-26-054586.md) | [105](/filings/0001193125-26-054586.md) | [108](/filings/0001193125-26-054586.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dfin/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $165.2m | 3,937,601 |  | Reduced −57,728 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $50.4m | 1,200,445 |  | Added +39,571 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $44.3m | 1,056,961 |  | Reduced −57,959 |
| [Alberta Investment Management Corp](/funds/1463559.md) | 2026-06-30 | $44.2m | 1,052,611 |  | Added +200,000 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $34.4m | 820,801 |  | Reduced −127,818 |
| [RICE HALL JAMES & ASSOCIATES, LLC](/funds/1230765.md) | 2026-06-30 | $32.5m | 775,119 |  | Reduced −4,918 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $29.3m | 699,080 |  | Added +12,749 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $26.6m | 633,806 |  | Added +7,389 |
| [WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC](/funds/1644956.md) | 2026-06-30 | $26.5m | 631,933 |  | Added +86,449 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $26.4m | 629,252 |  | Added +166,580 |

## Recent filings

[All 630 filings](/companies/dfin/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:00 ET | [8-K](/filings/0001193125-26-436951.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436951 |
| 2026-07-30 | 16:05 ET | [10-Q](/filings/0001193125-26-326099.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326099 |
| 2026-07-30 | 07:00 ET | [8-K](/filings/0001193125-26-324858.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-324858 |
| 2026-05-14 | 16:15 ET | [8-K](/filings/0001193125-26-224048.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-224048 |
| 2026-05-05 | 16:05 ET | [10-Q](/filings/0001193125-26-206350.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206350 |
| 2026-05-05 | 07:00 ET | [8-K](/filings/0001193125-26-204994.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204994 |
| 2026-04-21 | 07:00 ET | [8-K](/filings/0001193125-26-165048.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-165048 |
| 2026-04-01 | 07:30 ET | [DEF 14A](/filings/0001193125-26-135712.md) | Proxy statement, period 2026-05-13 | 0001193125-26-135712 |
| 2026-02-17 | 16:06 ET | [10-K](/filings/0001193125-26-054586.md) | Annual report, period 2025-12-31 | 0001193125-26-054586 |
| 2026-02-17 | 07:00 ET | [8-K](/filings/0001193125-26-052959.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-052959 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-054586.md), filed Feb 17, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/653a0a36-51f9-4cc2-a66d-b93388dda190)

## About the filer

- CIK: 1669811
- Tickers: DFIN
- Exchange: NYSE
- SIC code: 7380 Services-Miscellaneous Business Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.